TLSA - Tiziana Life Sciences Ltd. Common Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
--- --- --- --- --- --- --- ---

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Category: /stock/categories/na
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
VWAP:
2.03
RVol:

Events

Period Kind Movement Occurred At

Related News